Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 50.

Aguayo, D; Mueller, S M; Boutellier, U; Auer, M; Jung, H H; Flück, M; Toigo, M (2016). One bout of vibration exercise with vascular occlusion activates satellite cells. Experimental Physiology, 101(2):295-307.

Frey, B M; Gassner, C; Jung, H H (2015). Neurodegeneration in the elderly - When the blood type matters: An overview of the McLeod syndrome with focus on hematological features. Transfusion and Apheresis Science, 52(3):277-284.

Kressig, R W; Démonet, J F; Georgescu, D; Ibach, B; Jung, H H; Pihan, H; Monsch, A U; Mosimann, U O; Savaskan, Egemen (2015). Anwendung des hoch dosierten transdermalen Rivastigmin-Pflasters bei der Behandlung der Alzheimer-Erkrankung. Der Informierte Arzt, 4:20-22.

Mueller, S M; Aguayo, D; Zuercher, M; Fleischmann, O; Boutellier, U; Auer, M; Jung, H H; Toigo, M (2015). High-intensity interval training with vibration as rest intervals attenuates fiber atrophy and prevents decreases in anaerobic performance. PLoS ONE, 10(2):e0116764.

Frese, S; Ruebner, M; Suhr, F; Konou, T M; Tappe, K A; Toigo, M; Jung, H H; Henke, C; Steigleder, R; Strissel, P L; Huebner, H; Beckmann, M W; van der Keylen, P; Schoser, B; Schiffer, T; Frese, L; Bloch, W; Strick, R (2015). Long-Term Endurance Exercise in Humans Stimulates Cell Fusion of Myoblasts along with Fusogenic Endogenous Retroviral Genes In Vivo. PLoS ONE, 10(7):e0132099.

Feldmeyer, L; Baumann-Vogel, H; Tournier-Lasserve, E; Riant, F; Jung, H H; French, L E; Kamarashev, J (2014). Hyperkeratotic cutaneous vascular malformation associated with familial cerebral cavernous malformations (FCCM) with KRIT1/CCM1 mutation. European Journal of Dermatology, 24(2):255-257.

Rauch, P J; Müllhaupt, B; Biedermann, L; Manz, M G; Ruschitzka, F; Flammer, A; Segerer, S T; Mohebbi, N; Jung, H H; Moch, H; Ikenberg, K; Aguzzi, A; Nuvolone, M; Distler, O; Rauch, A; Fehr, T H; Gerber, B (2014). Systemische Amyloidosen. Swiss Medical Forum, 14(50):943-948.

Hof, D; Jung, H H; Bloch, K E (2013). Troponin T elevation in amyotrophic lateral sclerosis without cardiac damage. Amyotrophic Lateral Sclerosis, 14(1):75-77.

Poretti, A; Palla, A; Tarnutzer, A A; Petersen, J A; Weber, K P; Straumann, D; Jung, H H (2013). Vestibular impairment in patients with Charcot-Marie-Tooth disease. Neurology, 80(23):2099-105.

Weber, M; Neuwirth, C; Thierbach, J; Schweikert, K; Czaplinski, A; Petersen, J; Jung, H H; Birve, A; Marklund, S L; Andersen, P M (2012). ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival. Journal of Neurology, Neurosurgery, and Psychiatry, 83(3):351-353.

Jung, H H; Neumann, M; Bloch, K E (2012). Amyotrophic lateral sclerosis - diagnosis and treatment. Praxis, 101(14):907-914.

Petersen, J A; Jung, H H; Weller, M; Linnebank, M (2012). Autoimmune myasthenia gravis after sternal fracture. Case Reports in Neurology, 4(1):20-22.

De Franceschi, L; Scardoni, G; Tomelleri, C; Danek, A; Walker, R H; Jung, H H; Bader, B; Mazzucco, S; Dotti, M T; Siciliano, A; Pantaleo, A; Laudanna, C (2012). Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis. PLoS ONE, 7(2):e31015.

Petersen, J A; Toigo, M; Frese, S; Jung, H H (2012). Körperliches Training bei mitochondrialen Erkrankungen. Medizinische Genetik, 24(3):200-203.

Jung, H H; Bremer, J; Streffer, J; Virdee, K; Spillantini, M G; Crowther, R A; Brugger, P; van Broekhoven, C; Aguzzi, A; Tolnay, M (2012). Phenotypic variation of autosomal-dominant corticobasal degeneration. European Neurology, 67(3):142-150.

Miranda, M; Jung, H H; Danek, A; Walker, R H (2012). The chorea of McLeod syndrome: Progression to hypokinesia. Movement Disorders, 27(13):1701-1702.

Kühnlein, P; Jung, H H; Farkas, M; Keskitalo, S; Ineichen, B; Jelcic, I; Petersen, J; Semmler, A; Weller, M; Ludolph, A C; Linnebank, M (2011). The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12(2):136-139.

Polymenidou, M; Prokop, S; Jung, H H; Hewer, E; Peretz, D; Moos, R; Tolnay, M; Aguzzi, A (2011). Atypical prion protein conformation in familial prion disease with PRNP P105T mutation. Brain Pathology, 21(2):209-214.

Sommerstein, R; Jung, H H; Knoblauch, C (2011). Cerebral venous sinus thrombosis as a complication of a microendoscopic discectomy. European Neurology, 65(2):72-73.

Walker, R H; Jung, H H; Danek, A (2011). Chapter 7 - Neuroacanthocytosis. In: Weiner, W J; Tolosa, E. Hyperkinetic Movement Disorders. Edinburgh: Elsevier, 141-151.

Kellner, O; Sabova, K; Neumann, M; Jung, H H (2011). Die schwierige Diagnose der kortikobasalen Degeneration: Unterscheidung zwischen klinischem Syndrom und pathologischer Diagnose. Fortschritte der Neurologie, Psychiatrie, 79(11):660-667.

De Franceschi, L; Tomelleri, C; Matte, A; Brunati, A M; Bovee-Geurts, P H; Bertoldi, M; Lansoder, E; Tibaldi, E; Danek, A; Walker, R H; Jung, H H; Bader, B; Siciliano, A; Ferru, E; Mohandas, N; Bosman, G J (2011). Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. Blood, 118(20):5652-5663.

Gantenbein, A R; Damon-Perrière, N; Bohlender, J E; Chauveau, M; Latxague, C; Miranda, M; Jung, H H; Tison, F (2011). Feeding dystonia in McLeod syndrome. Movement Disorders, 26(11):2123-2126.

Chauveau, M; Damon-Perrière, N; Latxague, C; Spampinato, U; Jung, H H; Burbaud, P; Tison, F (2011). Head drops are also observed in McLeod syndrome. Movement Disorders, 26(8):1562-1563.

Jung, H H; Danek, A; Walker, R H (2011). Neuroacanthocytosis Syndromes. Orphanet Journal of Rare Diseases, 6:68.

Tomiyasu, A; et al; Jung, H H (2011). Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis. American Journal of Medical Genetics. Part B, 156(5):620-631.

Walterfang, M; Evans, A J; Looi, J C; Jung, H H; Danek, A; Walker, R H; Velakoulis, D (2011). The neuropsychiatry of neuroacanthocytosis syndromes. Neuroscience and Biobehavioral Reviews, 35(5):1275-1283.

Akhvlediani, T; Henning, A; Sándor, P S; Boesiger, P; Jung, H H (2010). Adaptive metabolic changes in CADASIL white matter. Journal of Neurology, 257:171-177.

Valko, P O; Hänggi, Jürgen; Meyer, Martin; Jung, H H (2010). Evolution of striatal degeneration in McLeod syndrome. European Journal of Neurology, 17(4):612-618.

Baumann, C R; Bassetti, C L; Hersberger, M; Jung, H H (2010). Excessive daytime sleepiness in Behçet's disease with diencephalic lesions and hypocretin dysfunction. European Neurology, 63(3):190.

Jung, H H (2010). Extraartikuläre weichteilrheumatische Erkrankungen (Weichteilrheumatismus) - Erkrankungen der Muskulatur. In: Domschke, W; Berger, M; Hohenberger, W; Meinertz, T; Possinger, K. Therapie-Handbuch. München: Elsevier, Urban & Fischer, O 15.3.

Heim, U; Sprott, H; Stebler, R; Simmen, B R; Trüeb, R M; Jung, H H; Kopp, G K (2010). Extraartikuläre weichteilrheumatische Erkrankungen (Weichteilrheumatismus) und Rückenschmerzen. In: Manger, B. Therapie-Handbuch. München: Elsevier, Urban & Fischer, O15.

Jung, H H; Bremer, J; Weller, M (2010). Gene therapy for myositis. In: Chernajovsky, Y; Robbins, P D. Gene therapy for autoimmune and inflammatory. Basel: Birkhäuser, 79-90.

Ramseier, S P; Jung, H H (2010). Morbus Wilson. Praxis, 99(3):175-182.

Schwager, S; Hochuli, M; Jung, H H (2010). Muskelschwäche: Differentialdiagnose und Abklärung. Praxis, 99(19):1121-1129.

Wegener, S; Bremer, J; Komminoth, P; Jung, H H; Weller, Michael (2010). Paraneoplastic necrotizing myopathy with a mild inflammatory component: a case report and review of the literature. Case Reports in Oncology, 3(1):88-92.

Hermann, D M; Jung, H H; Bassetti, C L (2009). Lateral medullary infarct with alternating and dissociated sensorimotor deficits: Opalski's syndrome revisited. European Journal of Neurology, 16(4):e72-e74.

Oechslin, E; Kaup, D; Jenni, R; Jung, H H (2009). Cardiac abnormalities in McLeod syndrome. International Journal of Cardiology, 132(1):130-132.

Jung, H H (2009). Neurologist-in-training. Schweizer Archiv für Neurologie und Psychiatrie, 160(2):77-80.

Semmler, A; Köhler, W; Jung, H H; Weller, M; Linnebank, M (2008). Therapy of X-linked adrenoleukodystrophy. Expert Review of Neurotherapeutics, 8(9):1367-1379.

Leenders, N; Jung, H H (2008). Functional imaging in neuroacanthocytosis. In: Walker, R H; Saiki, S; Danek, A. Neuroacanthocytosis Syndromes II. Berlin, Heidelberg: Springer, 163-173.

Burgunder, J M; Tan, E K; Wirthmüller, U; Jung, H H (2008). LRRK2 mutations are not frequent in Swiss patients with Parkinson’s disease. Schweizer Archiv für Neurologie und Psychiatrie, 159(7):412-418.

Marti, S; Baloh, R W; Jen, J C; Straumann, D; Jung, H H (2008). Progressive cerebellar ataxia with variable episodic symptoms - phenotypic diversity of R1668W CACNA1A mutation. European Neurology, 60(1):16-20.

Baumann, C R; Jenni, R; Jung, H H (2008). Severe extrapyramidal syndrome after exposition to isoamyl acetate vapour. Journal of Neurology, 255(5):762-763.

Geser, F; Tolnay, M; Jung, H H (2008). The neuropathology of McLeod syndrome. In: Walker, R; Sano, A; Danek, A. Neuroacanthocytosis Syndromes II. Berlin Heidelberg: Springer, 197-203.

Jung, H H (2008). Update on McLeod syndrome. In: Walker, R; Sano, A; Danek, A. Neuroacanthocytosis Syndromes II. Berlin Heidelberg: Springer, 53-58.

Rétey, J V; Adam, M; Khatami, R; Luhmann, U F O; Jung, H H; Berger, W; Landolt, H P (2007). A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clinical Pharmacology and Therapeutics, 81(5):692-698.

Wollmer, M A; Streffer, J R; Lütjohann, D; Tsolaki, M; Iakovidou, V; Hegi, T; Pasch, T; Jung, H H; von Bergmann, K; Nitsch, R M; Hock, C; Papassotiropoulos, A (2003). ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiology of Aging, 24(3):421-426.

Maddalena, A; Papassotiropoulos, A; Müller-Tillmanns, B; Jung, H H; Hegi, T; Nitsch, R M; Hock, C (2003). Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. Archives of Neurology, 60(9):1202-1206.

Wollmer, M A; Papassotiropoulos, A; Streffer, J R; Grimaldi, L M E; Kapaki, E; Salani, G; Paraskevas, G P; Maddalena, A; de Quervain, D; Bieber, C; Umbricht, D; Lemke, U; Bosshardt, S; Degonda, N; Henke, K; Hegi, T; Jung, H H; Pasch, T; Hock, C; Nitsch, R M (2002). Genetic polymorphisms and cerebrospinal fluid levels of tissue inhibitor of metalloproteinases 1 in sporadic Alzheimer's disease. Psychiatric Genetics, 12(3):155-160.

This list was generated on Fri Sep 22 20:27:15 2017 CEST.